The COVID-19 pandemic is expected to grow the medical tubing industry by a little more than 13% by 2021, according to an analysis by Markets and Markets.
The U.S. medical tubing market is expected to be worth $2.9 billion in 2021, up from this year’s value of $2.6 billion. With a consumer annual growth rate of 13.2%, the market growth can be attributed to the growing demand for medical tubes for drug delivery, catheter and cannulas, bulk disposable tubing and other special applications.
Markets and Markets projects that the silicone tubing segment is estimated to have the highest market share during the forecast period. Silicone is used in drug-eluting applications because of its versatility and high dielectric strength. Silicone also has resistance to high temperature, water resistance, mechanical strength and durability, which are expected to drive the demand of the tubing.
Drug delivery applications are expected to account for a large amount of the tubing market’s growth because of the growing usage of medical tubes as a device or channel of delivery in drug delivery systems.
The increasing number of COVID-19 cases globally will drive the demand for drug delivery systems, such as nasogastric tubes, nebulizers, spacer devices and others. Mayo Clinic’s Glass Shop has begun to see an increase in demand for glass nebulizers, while other companies are seeing increased demand for devices with tubing components, such as ventilators, due to the COVID-19 pandemic.
A robust industrial base and a large number of established manufacturers of medical tubing in the U.S. are expected to contribute to the medical tubing market’s growth as well, according to Markets and Markets.